awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58271878-75EA1B9B-803A-49B5-8FAD-838E97B3FB95
Q58271878-75EA1B9B-803A-49B5-8FAD-838E97B3FB95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58271878-75EA1B9B-803A-49B5-8FAD-838E97B3FB95
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
P2860
Q58271878-75EA1B9B-803A-49B5-8FAD-838E97B3FB95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58271878-75EA1B9B-803A-49B5-8FAD-838E97B3FB95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
abb0f1a621eedf64633001ef26cb32717d51d744
P2860
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.